Back to state act
Back to state act
Description
On 26 September 2024, the Biomedical Advanced Research and Development Authority (BARDA) awarded funding to ModeX Therapeutics to support the development of multispecific antibody for SARS-CoV-2. The ...
Intervention Details
Intervention Type
State aid, unspecified
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
26 Sep 2024
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Sectors
Affected Products
See all
This intervention is not part of any Thread yet.